← Back to Search

NMES for Reducing Fall Risk (NMES Trial)

N/A

Recruiting

Led By Odessa R. Addison, PhD DPT

Research Sponsored by VA Office of Research and Development

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

55 years or older

At risk for falls

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 12-months after exercise completion

Awards & highlights

NMES Trial Summary

This trial is testing a new method, neuromuscular electrical stimulation (NMES), to improve hip muscle strength and balance in older adults at risk for falls.

Who is the study for?

This trial is for individuals who are 55 years or older and at high risk of falling. It's not suitable for those with poorly controlled hypertension, home oxygen use, conditions that make resistance exercise or NMES use unsafe, dementia, or any other medical condition that the study team believes would interfere with participation.Check my eligibility

What is being tested?

The study tests a new program combining neuromuscular electrical stimulation (NMES) on hip muscles with balance and strengthening exercises to improve balance and mobility in order to reduce fall risks in older adults.See study design

What are the potential side effects?

Potential side effects may include discomfort from the electrical stimulation, muscle soreness from resistance training, skin irritation at the electrode sites used for NMES, and fatigue due to increased physical activity.

NMES Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 55 years old or older.

Select...

I am at risk of falling.

NMES Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 12-months after exercise completion

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~12-months after exercise completion

This trial's timeline: 3 weeks for screening, Varies for treatment, and 12-months after exercise completion for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Secondary outcome measures

Balance

Isometric Hip Abductor Strength

Mobility

+1 more

NMES Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: NMES + MMBIExperimental Treatment2 Interventions

Neuromuscular electrical stimulation applied to hip abductors along with participation in a multi-modality balance intervention

Group II: MMBIActive Control1 Intervention

Participation in a multi-modality balance intervention

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

VA Office of Research and DevelopmentLead Sponsor

1,620 Previous Clinical Trials

3,316,242 Total Patients Enrolled

Odessa R. Addison, PhD DPTPrincipal InvestigatorBaltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD

2 Previous Clinical Trials

42 Total Patients Enrolled

Media Library

Multi-Modality Balance Intervention (MMBI) Clinical Trial Eligibility Overview. Trial Name: NCT04969094 — N/A

Falling. Research Study Groups: NMES + MMBI, MMBI

Falling. Clinical Trial 2023: Multi-Modality Balance Intervention (MMBI) Highlights & Side Effects. Trial Name: NCT04969094 — N/A

Multi-Modality Balance Intervention (MMBI) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04969094 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any open enrollment opportunities for this research project?

"Affirmative. Clinicaltrials.gov records demonstrate that this experiment, which was established on April 1st 2022 is currently recruiting volunteers. A total of 80 participants are required from a single research centre."

Answered by AI

What is the current size of the cohort involved in this research?

"That is correct. According to information on clinicaltrials.gov, this medical study is presently recruiting 80 participants at one site. The trial was initially posted on April 1st 2022 and its details were last updated on July 1st of the same year."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Reducing Fall Risk With NMES

2022. "Reducing Fall Risk With NMES". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04969094.